Key facts
- Meroka’s last known valuation is $52.0M (Dec 2025).
- It has raised $21.1M; the latest was Early Stage VC ($15.1M) in Dec 2025.
- Notable investors include FJ Labs, 8VC, Slow Ventures, Interplay Ventures, Better Tomorrow Ventures.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Meroka
- ·The full record, as it builds
Funding rounds
No funding rounds for Meroka are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Meroka
Developer of a healthcare platform designed to protect and strengthen independent medical practices. The company offers operational tools, practical guidance, and a peer community, offering regulatory and administrative guidance, enabling independent physicians to maintain autonomy, operate outside corporate healthcare systems, and manage sustainable self-directed practices.
- Sector
- Healthcare
- HQ
- Wilmington, DE, United States
- Founded
- 2023
- Employees
- 11
- Website
- meroka.com/
- Ownership
- Privately Held (backing)
Meroka doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Meroka shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Meroka in its N-PORT filings yet. We sweep new filings monthly.